scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10897-007-9088-1 |
P698 | PubMed publication ID | 17492498 |
P50 | author | Rosalind Eeles | Q24640445 |
Claire Foster | Q56432355 | ||
Elizabeth Ormondroyd | Q56545413 | ||
Sue Davolls | Q64252617 | ||
P2093 | author name string | M Watson | |
C Moynihan | |||
A Ardern-Jones | |||
P2860 | cites work | Human genetic research, DNA banking and consent: a question of 'form'? | Q30664023 |
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling | Q34144333 | ||
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene | Q34354479 | ||
Disclosing individual results of clinical research: implications of respect for participants | Q34441798 | ||
Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics | Q34464458 | ||
'Coming down the line'-- patients' understanding of their family history of common chronic disease. | Q34629496 | ||
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis | Q35634237 | ||
Perception of risk in women with a family history of breast cancer | Q35976086 | ||
Disclosure of genetic information obtained through research | Q36052698 | ||
Men's decision-making about predictive BRCA1/2 testing: the role of family. | Q36164813 | ||
Factors associated with emotional and behavioural problems among school age children of breast cancer patients | Q36613470 | ||
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. | Q36618985 | ||
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort | Q36644314 | ||
Research samples from families with genetic diseases: a proposed code of conduct | Q40382480 | ||
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants | Q40515868 | ||
Offering results to research participants | Q43186739 | ||
Performance of breast self-examination by women at high risk for breast cancer | Q43976858 | ||
Duty to recontact: a legal harbinger? | Q44967970 | ||
Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing | Q47381625 | ||
Ethical issues in genetic research: disclosure and informed consent | Q48056443 | ||
Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study | Q48485451 | ||
Relation of family history of prostate cancer to perceived vulnerability and screening behavior. | Q48559708 | ||
Predictive testing for BRCA1 and 2 mutations: a male contribution | Q48601921 | ||
Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility | Q48629855 | ||
Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. | Q51070582 | ||
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. | Q51076471 | ||
Effect of fear-arousing communications. | Q51367566 | ||
Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems | Q57694564 | ||
Genetic predisposition to prostate cancer | Q57694715 | ||
Women with breast cancer: perception of family functioning and adjustment to illness | Q67961689 | ||
How families communicate about HNPCC genetic testing: Findings from a qualitative study | Q73293994 | ||
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer | Q73603283 | ||
The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer | Q81571149 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 527-538 | |
P577 | publication date | 2007-05-11 | |
P1433 | published in | Journal of Genetic Counseling | Q6295247 |
P1476 | title | Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives. | |
P478 | volume | 16 |
Q47558524 | "I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings |
Q35008569 | An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group |
Q37790290 | Communicating genetic risk information within families: a review |
Q33334605 | Communicating the results of clinical research to participants: attitudes, practices, and future directions |
Q35814864 | Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research |
Q36143162 | Family decision maker perspectives on the return of genetic results in biobanking research |
Q47566263 | Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives |
Q39323888 | Impact of a genetic diagnosis of a mitochondrial disorder 5-17 years after the death of an affected child. |
Q48592048 | Impact on parents of receiving individualized feedback of psychological testing conducted with children as part of a research study |
Q39298381 | Influences of race and breast density on related cognitive and emotion outcomes before mandated breast density notification. |
Q50559453 | Measuring the degree of closeness to the cancer experience: development and initial validation of the CONNection to the Experience of Cancer Scale (CONNECS). |
Q37376130 | Men in the women's world of hereditary breast and ovarian cancer--a systematic review |
Q38188482 | Negative autopsy and sudden cardiac death. |
Q34408320 | Participants' preference for type of leaflet used to feed back the results of a randomised trial: a survey. |
Q36197118 | Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject |
Q26801429 | Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician |
Q39519496 | Perspectives of surrogate decision makers for critically ill patients regarding gene variation research |
Q37157578 | Providing research results to participants: attitudes and needs of adolescents and parents of children with cancer |
Q28710366 | Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group |
Q36198371 | Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles |
Q34000877 | Return of genomic results to research participants: the floor, the ceiling, and the choices in between |
Q27026989 | Return of individual research results and incidental findings: facing the challenges of translational science |
Q90135232 | Stakeholders' perspectives on the post-mortem use of genetic and health-related data for research: a systematic review |
Q37477355 | Support Seeking or Familial Obligation: An Investigation of Motives for Disclosing Genetic Test Results |
Q86220760 | The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study |
Q36470928 | Timing and context: important considerations in the return of genetic results to research participants |
Q38882097 | Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered |
Search more.